

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 255.94 | 222.26 | 193.69 | 225.50 | 141.38 |
| Total Expenses | 214.53 | 190.03 | 186.94 | 192.30 | 135.01 |
| Profit Before Tax | 41.41 | 31.45 | 6.75 | 33.19 | 6.37 |
| Profit After Tax | 30.98 | 23.13 | 6.07 | 23.75 | 6.44 |
| Operating Profit After Depreciation | 49.79 | 41.02 | 15.81 | 35.30 | 7.93 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 223.42 | 211.53 | 195.21 | 119.31 | 119.14 |
| Total Non Current Assets | 286.37 | 227.76 | 213.14 | 178.91 | 143.71 |
| Total Current Assets | 47.15 | 72.45 | 68.05 | 21.81 | 27.34 |
| Total Assets | 333.52 | 300.20 | 281.19 | 200.72 | 171.05 |
| Total Shareholder's Fund | 211.24 | 179.41 | 155.93 | 149.97 | 126.22 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 63.36 | 60.48 | 44.10 | 42.34 | 23.51 |
| Net Cash Used In Investing Activities | -39.58 | -35 | -20.79 | -43.79 | -27.71 |
| Net Cash Used In Financing Activities | -24.05 | -25.13 | -24.33 | 1.09 | 3.21 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 253.48 | 222.17 | 193.56 | 225.50 | 141.38 |
| Total Expenses | 209.62 | 188.69 | 185.69 | 192.30 | 134.97 |
| Profit Before Tax | 43.86 | 32.71 | 7.87 | 33.19 | 6.41 |
| Profit After Tax | 33.44 | 24.38 | 7.19 | 23.75 | 6.47 |
| Operating Profit After Depreciation | 52.24 | 42.27 | 16.93 | 35.30 | 7.97 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 215.65 | 211.41 | 195.05 | 206.53 | 119.14 |
| Total Non Current Assets | 288.83 | 230.98 | 214.40 | 220.82 | 143.76 |
| Total Current Assets | 44.27 | 70.76 | 67.65 | 63.05 | 27.32 |
| Total Assets | 333.10 | 301.75 | 282.06 | 283.87 | 171.08 |
| Total Shareholder's Fund | 214.31 | 180.86 | 156.62 | 149.42 | 126.26 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 62.80 | 61.23 | 44.93 | 42.33 | 23.54 |
| Net Cash Used In Investing Activities | -39.28 | -35.04 | -22.04 | -43.69 | -27.71 |
| Net Cash Used In Financing Activities | -24.15 | -25.83 | -24.32 | 1.09 | 3.21 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 81.41 | 77.69 | 78.73 | 72.59 | 65.09 |
| Total Expenses | 57.04 | 54.53 | 54.62 | 48.84 | 45.91 |
| Profit Before Tax | 9.98 | 10.06 | 12.04 | 12.48 | 9.21 |
| Profit After Tax | 6.16 | 7.24 | 8.83 | 9.18 | 7.17 |
| Operating Profit after Depreciation | 25.16 | 23.78 | 24.96 | 24.66 | 20 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 78.56 | 75.58 | 76.26 | 70.28 | 64.15 |
| Total Expenses | 54.75 | 52.39 | 52.29 | 46.45 | 44.32 |
| Profit Before Tax | 10.55 | 10.97 | 12.57 | 13.12 | 10.05 |
| Profit After Tax | 6.71 | 8.14 | 9.36 | 9.85 | 8.01 |
| Operating Profit after Depreciation | 25.11 | 24.18 | 24.94 | 24.93 | 20.77 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Apollo Hospitals Enterprise Ltd | ₹8,495.95 | ₹1,22,158.73 |
| Max Healthcare Institute Ltd | ₹1,008.95 | ₹98,195.43 |
| Fortis Healthcare Ltd | ₹988.95 | ₹74,661.59 |
| Aster DM Healthcare Ltd | ₹814.20 | ₹42,185.41 |
| Narayana Hrudayalaya Ltd | ₹1,861.80 | ₹38,047.89 |
| Fund Name | AUM |
|---|---|
| Nippon India Pharma Fund | 1.29% |
| JM Small Cap Fund | 1.11% |
| Aditya Birla SL Pharma & Healthcare Fund | 1.01% |
| JM Value Fund | 0.84% |
| Bandhan Innovation Fund | 0.57% |
On 2 September 2026
22 May 2026, 02:41 pm
Of Rs 0.5 per share
22 May 2026, 10:27 am
Suraksha Diagnostic Ltd has added 4.27% over last one month compared to 9.48% gain in BSE Healthcare index and 4.15% drop in the SENSEX
22 May 2026, 09:30 am
On 21 May 2026
14 May 2026, 03:04 pm
Suraksha Diagnostic fell 2.06% to Rs 265.85 after its group chief financial officer (CFO) and key managerial personnel (KMP), K S Ravindra, has tendered his resignation due to personal reasons.
02 Mar 2026, 12:56 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.